June in tweets

Summer is conference high season, and June was no exception. PLabbers fanned out across the country (and San Francisco) for three events, including two patient-advocacy-group-led research meetings. The first conference was the 22nd annual Ara Parseghian Medical...

May in tweets

YC Demo Day marked the beginning of Spring and a new chapter of growth for PLab. For two years (2014 and 2015) we operated not just as a lean startup, but as an ultra-lean startup — you could call it budgetary caloric restriction. Read more about how we made the...
A yeast model of cystic fibrosis

A yeast model of cystic fibrosis

At PLab we’re always on the lookout for new publications describing simple animal models of rare genetic diseases. The more non-obvious the model/disease fit appears at first blush, the more exciting are any results that confirm therapeutic relevance in humans...

April in tweets

We kicked off April with Tamy’s first post on the PLab blog. She and Tom have been working hard to launch our Drosophila NGLY1 HTS campaign. Tamy describes an unexpected challenge we encountered during assay development. DMSO and Drug Discovery...
Why Y Combinator?

Why Y Combinator?

11-year old startup accelerator Y Combinator – “YC” for those in the know – has reached national (and international) acclaim for incubating today’s premier tech unicorns back when they were hatchlings. Companies with instant name recognition, like Airbnb (W09)...
Translate »